FindTrial
Sign In

Development and validation of a predictive model for high-risk human papillomavirus infection in adult women

Development and validation of a predictive model for high-risk human papillomavirus infection in adult women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091957
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-11-10
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Training set:Risk factors for high-risk human papillomavirus infection
validation set:Risk factors for high-risk human papillomavirus infection

Sponsors

Shantou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years. 2.female patients undergoing HPV nucleic acid testing.

Exclusion criteria

Exclusion criteria: 1.Patients with missing clinical history data and auxiliary examination records. 2.Combined with other tumors. 3.Combined with autoimmune diseases. 4.Being in pregnancy or breastfeeding. 5.With cognitive impairment or mental illness. 6.Combined with serious liver, lung and brain diseases

Design outcomes

Primary

MeasureTime frame
high-risk human papillomavirus infection;—

Countries

China

Contacts

Public ContactZheng Chunqin

Shantou Central Hospital

467430374@qq.com+86 13682950198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026